Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,977 public trials 2,028 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Silymarin (Milk Thistle Extract) in Treating Patients With Acute Lymphoblastic Leukemia Who Are Receiving Chemotherapy

NCT00055718

Conditions
Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Drug/Agent Toxicity by Tissue/Organ, +11 more
Locations
  • Miami Children's Hospital Miami, Florida, United States
  • Winthrop University Hospital Mineola, New York, United States
  • Mount Sinai School of Medicine New York, United States
  • Herbert Irving Comprehensive Cancer Center at Columbia University New York, United States
View Trial Details
Completed

MLN4924 for the Treatment of Acute Myelogenous Leukemia, Myelodysplastic Syndrome, and Acute Lymphoblastic Leukemia

NCT00911066

Conditions
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Bone Marrow Diseases, +15 more
Locations
  • Stanford University Medical Center Stanford, California, United States
  • Robert H. Lurie Comprehensive Cancer Center Northwestern University Chicago, Illinois, United States
  • Johns Hopkins Kimmel Cancer Center Baltimore, Maryland, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details

Related conditions